Name of opportunity: 👀
IDEXX Laboratories, Inc.
Impressive Q4 results 📈
IDEXX Laboratories has shot up by 11.13% in price in the past day, after its recent earnings report. The report highlighted that there was an increase of 6% in revenue, as the company reported $954 million for Q4. Yesterday, it was the highest performing stock in the S&P 500.
IDEXX is currently performing well financially, as the company is excelling in cash flow generation, revenue performance, and profitability. Analysts are calling this stock a ‘buy’ right now - should you invest?
How hot is this investment opportunity? 🔥🔥🔥
Analysts predict the price of IDEXX Laboratories, Inc. might increase from $469.04 to $562.20 in the next 12 months. If you invested $1000, you might profit $198.62.
These strong Q4 results might have attracted investors, resulting in the stock price soaring. The 6% year-on-year increase surpassed analysts expectations, with the revenue increase accredited to the Companion Animal Group (CAG). This might have been because of the increase in demand for health tests for pets. IDEXX’s products and services available to vets also include veterinary practice management software.
IDEXX Laboratories have recently announced the launch of Cancer DX, which is a diagnostic test which can detect lymphoma in dogs. This screening test is set to hit U.S and Canadian markets late next month. This news highlights IDEXX’s innovation in the pet healthcare industry, boosting investor confidence.
Global leader in pet healthcare 🐶
IDEXX Laboratories, Inc. is an American multinational corporation that develops and manufactures products and services for companion animal veterinary markets, amongst others. The company is headquartered in Westbrook, Maine, United States. For its EMEA division, the headquarters are in Hoofddorp, Netherlands.
Which neme?: 🔍
‘Top Gainers Today’, ‘Stocks On The Move’.
Download Nemo Money to check out IDEXX Laboratories, Inc. New users can grab our registration bonus up to a maximum of $50 on first deposit. Terms and conditions apply.
